Vertebroplasty data hint atnegative effect on survival
Researchers were stunned when preliminary results of an ongoing study showed that patients who undergo vertebroplasty may die sooner than patients with vertebral fractures who do not undergo the procedure.
Researchers were stunned when preliminary results of an ongoing study showed that patients who undergo vertebroplasty may die sooner than patients with vertebral fractures who do not undergo the procedure.
“It doesn’t make any sense to us,” said coauthor Dr. Robert J. McDonald from Mayo Clinic’s Medical Scientist Training Program.
McDonald and colleagues in Rochester, MN, compared survival rates of patients treated with vertebroplasty for vertebral fractures with those treated conservatively. A preliminary data analysis suggested the former had a significantly reduced life expectancy when compared with the latter.
The study remains a work-in-progress, however, and McDonald advised against jumping to conclusions before final results are in. He released the preliminary findings at the 2008 RSNA meeting.
Seven Takeaways from Meta-Analysis of PSMA Radiotracers for Prostate Cancer Imaging
December 1st 2023In a newly published meta-analysis of 24 studies, researchers noted that the PSMA PET radiotracer 18F PSMA-1007 may provide more benefit than 68Ga Ga-PSMA-11 for primary staging of patients with prostate cancer and detection of local lesion recurrence, but also has drawbacks with higher liver uptake and multiple reports of false positive bone lesions.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.
